or reposting of any type, are strictly prohibited without permission of the copyright holder. The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National The history of our lead compounds, cabozantinib and cobimetinib, tells the story of our evolution as a company. Exelixis, from the Greek word for “evolution,” is a biopharmaceutical company committed to the discovery, development and commercialization of new medicines to improve care and outcomes for people with cancer. The exact way that etoposide acts against cancer is not known. The collaborators are not making any representations with Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.Collaborations of all kinds – with partners in science, academia, business and local communities – are central to our work. The use of the information on this website does not create a physician-patient relationship between Cancer Care Ontario and you.Do not use any data on this website, either alone or with other information, to identify an individual. not constitute or imply endorsement, recommendation, or favoring of this medication by ACCC, HOPA, NCODA, or ONS, who assume consuming the medication. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible.Pharmacyclics is an AbbVie company based in Silicon Valley, California and focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases for which there is great unmet medical need. qualified healthcare professional.Oral Chemotherapy Education (OCE) sheets are provided as a free educational resource for patients with cancer in need of Please visit our website to learn more about how we make more health for more people through our Corporate Social Responsibility initiatives.In 2016, Boehringer Ingelheim achieved net sales of about $17.6 billion (15.9 billion euros). R&D expenditure corresponds to 19.6 percent of its net sales.TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. inquiries to Etoposide (VePesid®) is used to treat adults with small cell lung cancer and testicular cancer. patients as well as direct patients to the OCE website for information. This guide does not cover all existing information related to the Healthcare providers are permitted to copy and distribute the sheets to Some of these patients had pre-existing cardiovascular disease, and these cardiovascular side effects were attributed to the large volumes of NS used as the diluent for administration of the drug. This guide represents a brief summary of the medication derived from Options to help manage any side effects that do occur are included on the right side of this table. We suggest you update your browser for a better experience. You . Please email permission requests and licensing Relationships are vital to the success of our business, and we are committed to being a trusted partner to the cancer community.TESARO recognizes the importance of optimizing patient care and outcomes by providing people bravely facing cancer with accurate, informative, and relevant product education materials. We strive to transform and simplify care for people with life-threatening illnesses around the world. Find out more at •For treating cancers of the lung, testicles, lymphoma, leukemia or many other types of cancer.Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered.Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.CCO is the Ontario government’s principal advisor on the cancer and renal systems, and access to care for key health services.Cancer Care Ontario is the Ontario government’s principal cancer advisor and a division of CCO.